Cellectis S.A. (CLLS)

Every figure this model derived for CLLS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 2,360,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 73,233,000 CashAndCashEquivalents 2025-12-31
current assets 122,043,000 CurrentAssets 2022-12-31
current liabilities 145,752,000 CurrentLiabilities 2025-12-31
equity 75,901,000 EquityAttributableToOwnersOfParent 2025-12-31
interest expense 51,064,000 FinanceCosts 2025-12-31
ocf -39,401,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 72,949,000 Revenue 2025-12-31
sbc 6,110,000 AdjustmentsForSharebasedPayments 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up CLLS on one particular measure came for.

RatioValue
cash operating margin-52.49
current ratio0.84
current ratio reported0.84
dilution pct10.73
fcf margin-57.25
growth cv2.05
interest cover-0.65
operating margin-45.34
owner earnings margin-65.62
revenue growth75.76
revenue growth per share58.72
roic-68.59
rule of 4030.42
sbc pct revenue8.38

What to be careful about

What this model itself distrusts about CLLS's figures. Written by the derivation as it ran, not added afterwards.